Tamsulosin: Alpha Blocker, Benign Prostatic Hyperplasia, Astellas Pharma, Boehringer- Ingelheim, Alpha 1 Receptor, Alpha- 1A Adrenergic Receptor - Tapa blanda

Reseña del editor

Please note that the content of this book primarily consists of articles available from Wikipedia or other free sources online. Tamsulosin (rINN) is an α1a-selective alpha blocker used in the symptomatic treatment of benign prostatic hyperplasia (BPH). Tamsulosin was developed by Yamanouchi Pharmaceuticals (now part of Astellas Pharma) and is marketed by various companies under licence, including Boehringer-Ingelheim and CSL. Tamsulosin hydrochloride extended-release capsules are marketed under the trade names Flomax, Flomaxtra and Urimax, though generic non-modified release capsules are still approved and marketed in many countries, such as Canada. The U.S. patent for Flomax expired October 2009.